Biotech stocks in focus today include Apollomics after its return to Nasdaq compliance, while Iovance and AVITA trade ahead of their Q2 earnings updates. Annexon is awaiting topline data for dry age-related macular degeneration with geographic atrophy, and Veradermics moved after reporting positive results (details not provided). Net near-term signal looks largely event-driven and modest for the sector.
Biotech stocks in focus today include Apollomics after its return to Nasdaq compliance, while Iovance and AVITA trade ahead of their Q2 earnings updates. Annexon is awaiting topline data for dry age-related macular degeneration with geographic atrophy, and Veradermics moved after reporting positive results (details not provided). Net near-term signal looks largely event-driven and modest for the sector.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
neutral
Sentiment Score
0.08
Ticker Sentiment
